Reversibility of promoter induced hepatic focal lesion growth in mice

Carcinogenesis

Volumn 17, Issue 7, 1996, Pages 1403-1409

  Kolaja, Kyle L ^a,c   Stevenson, Donald E ^b   Walborg Jr , Earl F ^b   Klaunig, James E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dermigen Inc   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIELDRIN; DIETHYLNITROSAMINE; PHENOBARBITAL; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASOPHIL; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; DNA SYNTHESIS; EOSINOPHIL; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BODY WEIGHT; CARCINOGENS; CELL DIVISION; DIELDRIN; DIET; DIETHYLNITROSAMINE; EOSINOPHILS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; ORGAN SIZE; PHENOBARBITAL; PRECANCEROUS CONDITIONS;

EID: 0029902137     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.7.1403     Document Type: Article

References (66)

1. Pitot, H.C. (1990) Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu. Rev. Pharmacol. Toxicol., 30, 465-500.
2. Schulte-Hermann, R.S. (1987) Tumor promotion in the liver. Archiv. Toxicol., 57, 147-158.
3. Klaunig, J.E. (1993) Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Environ. Health Perspect., 101, 235-249.
4. Butterworth, B.E. (1990) Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenesis potential. Mutat. Res., 239, 117-132.
5. Butterworth, B.E. and Goldsworthy, T.L. (1991) The role of cell proliferation in multi-stage carcinogenesis. Proc. Soc. Exp. Biol. Med., 198, 683-687.
6. Ponomarkov, V. Tomatis, L. and Turusov, V. (1976) The effects of long-term administration of phenobarbitone in CF-1 mice. Cancer Lett., 1, 165-172.
7. Rossi, L., Ravera, M., Repetti, G. and Santi, L. (1977) Long term administration of DDT or phenobarbital-Na in Wistar rats. Int. J. Cancer, 19, 179-195.
8. Butler, W.H. and Hempsall, V. (1978) Histochemical observations on nodules induced in mouse liver by phenobarbitone. J. Pathol., 125, 155-161.
9. Kitagawa, T., Watanabe, R. and Sigano, H. (1980) Induction of gamma-glutamyl transpeptidase activity by dietary phenobarbital in 'spontaneous' hepatic tumors of C3H mice. Gann, 71, 536-642.
10. Williams, G.M. (1980) Pathogenesis liver cancer caused by chemical carcinogens. Biochim. Biophys. Acta, 605, 167-189.
11. Stevenson, D.E., Walborg, E.F., Jr. and Klaunig, J.E. (1995) The species specificity of dieldrin- or phenobarbital- induced hepatocarcinogenesis: case studies with implications for human health risk assessment. In Growth Factors and Tumor Promotion: Implications for Risk Assessment. Wiley and Liss, NY, pp. 337-345.
12. Williams, G.M. and Numoto, S. (1985) Promotion of mouse liver neoplasms by the organochloride pesticides chlordane and heptachlor in comparison to DDT. Carcinogenesis, 5, 1689-1693.
13. WHO, Environmental Health Criteria 91; World Health Organization, Geneva.
14. Cabral, J.H.P., Hall, R.K., Bronczyk, S.A. and Shubik, P. (1979) A carcinogenicity of the pesticide dieldrin in hamsters. Cancer Lett., 6, 241-246.
15. Wright, A.S., Donninger, C., Greenland, R.D., Stemmer, K.L. and Zavon, M.R. (1978) The effects of prolonged ingestion of dieldrin on the livers of male rhesus monkeys. Ecotoxicol. Environ. Saf., 1, 477-502.
16. NCI (1978) Bioassay of aldrin and dieldrin for possible carcinogenicity, Bethesda, MD, National Cancer Institute (DHEW Publication No. (NIH) 78-821,2).
17. Fitzhugh, O.G., Nelson, A.A. and Quaife, M.L. (1964) Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol., 2, 551-561.
18. Kolaja, K.L., Stevenson, D.E., Walborg, E.F., Jr. and Klaunig, J.E. (1996) Species specific tumor promotion of dieldrin: effect on apoptosis and DNA synthesis in focal lesions. Carcinogenesis, 17, in press.
19. Peraino, C., Fry, R.J.M. and Staffeldt, R.J.M. (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced by 2-acetyl amino fluorine. Cancer Res., 31, 1506-1512.
20. Goldsworthy, T., Campbell, H.A. and Pitot, H.C. (1984) The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis, 5, 67-71.
21. Schulte-Hermann, R., Krapp-Grasl, B., Bursch, W., Gerbracht, U. and Timmermann-Trosnier, I. (1989) Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver. Toxicol. Pathol., 17, 620-650.
22. Weghorst, C.M., Devoe, D.E., Henneman, J.R. and Ward, J.M. (1989) Promotion of hepatocellular foci and adenomas by di(2-ethylhexl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age. Exp. Toxicol. Pathol., 45, 423-431.
23. Weghorst, C.M., Periera, M.A. and Klaunig, J.E. (1989) Strain differences in hepatic tumor promotion by phenobarbital in diethyl-nitrosamine and dimethylnitrosamine initiated infant male mice. Carcinogenesis, 10, 1409-1412.
24. Schulte-Hermann, R., Timmermann-Trosnier, I., Barthel, G. and Bursch, W. (1990) DNA synthesis, apoptosis, and phenotypic expression as a determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5135.
25. Kolaja, K.L, Stevenson, D.E., Walrborg, E.F., Jr. and Klaunig, J.E. (1996) Dose-dependent effects of phenobarbital promotion on preneoplastic hepatic lesions in Fisher 344 rats and B6C3F1 mice: effect on DNA synthesis and apoptosis. Carcinogenesis, 17, 947-954.
26. Rabes, H.M., Scholze, D. and Jantsch, B. (1972) Growth kinetics of diethylnitrosamine induced enzyme-deficiency 'preneoplastic' liver cell foci in vivo and in vitro. Cancer Res., 32, 2577-81.
27. Teebor, G.W. and Becker, F.F. (1971) Regression and persistence of hyperplastic hepatic nodules induced by N-2-fluoroacetamide and their relationship to hepatocarcinogenesis. Cancer Res., 31, 1-9.
28. Glauert, H.P., Schwarz, M. and Pitot, H.C. (1986) The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of long-term feeding of purified diets after the withdrawal of phenobarbital. Carcinogenesis, 7, 117-121.
29. Enomoto, K. and Farber, E. (1982) Kinetics of phenotypic maturation of remodeling hyperplastic nodules during liver carcinogenesis. Cancer Res., 42, 2330-2338.
30. Lipsky, M.M., Tanner, D.C., Hinton, D.E. and Trump, B.F. (1984) Reversibility, persistence and progression of safrole-induced mouse liver lesions following cessation of exposure. In Popp, J.A. (ed.), Mouse Liver Neoplasia: Current Perspectives. Hemisphere, New York, pp. 161-177.
31. Ito, N., Hananouchi, M., Sugihara, S., Shirai, T., Tsuda, H., Fukushima, S. and Nagasaki, H. (1976) Reversibility and irreversibility of liver tumors in mice induced by the a isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res., 36, 2227-2234.
32. Ruebner, B.H., Gershwin, M.E., Meierhenry, E.F., Hsieh, L.S. and Dunn, P.L. (1984) Irreversibility of liver tumors in C3H mice. J. Natl Cancer Inst., 73, 493-498.
33. Goodman, J.I., Ward, J.M., Popp, J.A., Klaunig, J.E. and Fox, T.R. (1989) Mouse liver carcinogenesis:mechanisms and relevance. Fundam. Appl. Toxicol., 17, 651-665.
34. Stevenson, D.E., McClain, R.M., Popp, J.A., Ward, J.M. and Pitot, H.C. (1990) Mouse liver carcinogenesis: mechanisms and species comparisons. Wiley and Liss, NY.
35. Maronpot, R.R., Haseman, J.K., Boorman, G.A., Eustic, S.E., Rao, G.N. and Huff, J.E. (1987) Liver lesions m B6C3F1 mice: National Toxicology Program experience and position. Archiv. Toxicol., 10 (Suppl.), 10-26.
36. Enzmann, H and Bannasch, P (1987) Potential significance of hepatocellular heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis, 8, 1606-1612.
37. Ward, J.M., Ohshima, M., Lynch, P. and Riggs, C. (1984) Di(2-ethylhexyl) phthalate but not phenobarbital promotes diethylnitrosamine initiated hepatocellular proliferative lesions after short term exposure in male B6C3F1 mice. Cancer Lett., 24, 49-55.
38. Weghorst, C.M., Devoe, D.E., Henneman, J.R. and Ward, J.M. (1989) Promotion of hepatocellular foci and adenomas by di(2-ethylhexl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age. Exp. Toxicol. Pathol., 45, 423-439.
39. Saady, J.J. and Poklis, A. (1990) Determination of chlorinated hydrocarbon pesticides by solid phase extraction and capillary GC with electron capture detection. J. Anal. Toxicol., 14, 301-304.
40. Ward, J.M. (1980) Morphology of hepatocellular neoplasms in B6C3F1 mice. Cancer Lett., 9, 319-325.
41. Frith, J. and Ward, J.M. (1979) A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol., 3, 329-351.
42. 3H]-thymidine administered by injection or osmotic pump. Carcinogenesis, 11, 2245-2251.
43. Pugh, T.D., King, J.H., Koen, H., Nychka, D., Chover, J., Wahba, G., He, Y. and Goldfarb, S. (1983) Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res., 43, 1261-1268.
44. Bursch, W., Taper, H.S., Lauer, B. and Schulte-Hermann, R. (1985) Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch (Cell Pathol.), 50, 153-166.
45. Bursch, W.B., Lauer, B., Timmermann-Trosenier, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-158.
46. Stinchcombe, S., Buchmann, A., Bock, K.W. and Scwarz, M. (1995) Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumor promotion in rat liver. Carcinogenesis, 16, 1271-1275.
47. Gad, S. and Weil, C.S. (1986) Statistics and experimental design for toxicologists. Telford Press, New Jersey.
48. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheldon, E.B. (1995) Nongenotoxic hepatocarcinogens stimulate DNA synthesis and their withdraw induces apoptosis, but in different hepatocyte population. Carcinogenesis, 16, 1693-1699.
49. Bayly, A.C., Roberts, R.A. and Dive, C. (1995) Suppression of liver cell apoptosis m vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol., 125, 197-203.
50. Lucier, G.W., Tritscher, A., Goldsworthy, T., Foley, J., Clark, G., Goldstein, J. and Maronpot, R. (1991) Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res., 51, 1391-1397.
51. Wyllie, A.H., Kerr, J.F.R. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
52. Corcoran, G.B., Fix, L., Jones., D.P., Molsen, M.T., Nicotera, P., Oberhammer, F.A. and Buttyan, R. (1994) Apoptosis: molecular control point in toxicity. Toxicol. Appl. Pharmacol., 128, 169-181.
53. Tatesumota, M., Nagamine, Y. and Farber, E. (1983) Redifferentation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res., 43, 5049-5058.
54. Morris, R. (1989) Testing statistical hypothesis about rat liver foci. Toxicol. Pathol., 17, 569-579.
55. Yager, J.D., Roebuck, B.D., Paluszcyk, T.L. and Memoli, V.A. (1986) Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis, 7, 2007-2012.
56. Noronha, R.F.X. and Goodall, C.M. (1983) Enhancement by testosterone of diethylnitrosamine carcinogenesis in lung, liver, and kidney of inbred NZR/Gd female rats. Carcinogenesis, 4, 613-616.
57. Kemp, C.J., Leary, C.N. and Drinkwater, N.R. (1989) Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc Natl Acad. Sci. USA, 86, 7505-7509.
58. Tsuda, H., Masui, T., Imaida, K., Fukushima, S. and Ito, N. (1984) Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats. Gann, 75, 871-875.
59. Buckley, A.R., Putnam, C.W. and Russell, D.H. (1985) Prolactin is a tumor promoter in rat liver. Life Sci., 37, 2569-2575.
60. Mochizuki, Y., Sawada, N. and Furukawa, K. (1981) Effect of bolandiol dipropionate (anabiol), an anabolic hormone, on diethylnitrosamine-induced hepatocarcinogenesis in rats. Gann, 72, 969-973.
61. 1-induced preneoplastic hepatic foci in rat liver. Carcinogenesis, 8, 101-107.
62. Newberne, P.M. and Schrager, T. (1983) Promotion of gastointestinal tract tumors in animals: dietary factors. Environ. Health Perspect., 50, 71-83.
63. Sidransky, H., Garett, C.T., Murty, C.N., Verney, E. and Robinson, E.S. (1985) Influence of dietary tryptophan on the induction of gamma-glulamyl transpeptidase-positive foci in the livers of rats treated with hepatocarcinogen. Cancer Res., 45, 4844-4847.
64. Hei, T.K. and Sudilovsky, O. (1985) Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats. Cancer Res., 45, 2700-2705.
65. Ames, B.N. and Gold, L.S. (1990) Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad. Sci. USA, 87, 7772-7776.
66. Cohen, S.M. and Ellwein, L.B. (1991) Genetic errors, cell proliferation, and carcinogenesis. Cancer Res., 51, 6393-6505.